Since launching its GlobaleMed subsidiary in February, Miami Lakes, FL-based World Diagnostics has entered into agreements with local distributors in Chile, Romania, South Africa, and Poland to speed
Since launching its GlobaleMed subsidiary in February, Miami Lakes, FL-based World Diagnostics has entered into agreements with local distributors in Chile, Romania, South Africa, and Poland to speed delivery of its diagnostic products and increase its presence in non-U.S. markets. The GlobaleMed system offers online access to product ordering, product specifications, product demonstrations, and live chat with medical technicians on the Web. The system also allows customers to choose to view some information in their home language; however, the animated demonstrations appear to be available only in English. World Diagnostics plans to have a local presence in at least 33 countries, including such developing markets as Malaysia, Thailand, and Iceland, by years end.
© 2000 Miller Freeman, Inc., a United News & Media company.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.